YAP and the Hippo pathway in cholangiocarcinoma.

Journal of Gastroenterology
Takaaki SugiharaRory L Smoot

Abstract

Cholangiocarcinoma (CCA) has an increasing incidence and remains a difficult to treat malignancy. In a search for more effective treatment options, progress has been made in identifying molecular drivers of oncogenic signaling including IDH mutations and FGFR2 fusions. In addition, multiple investigators have identified increased activity of YAP, the effector protein of the Hippo pathway, in CCA. The Hippo pathway regulates organ size, cellular proliferation, and apoptosis via YAP, a transcriptional co-activator. Targeting of the pathway has been difficult due the lack of a dedicated cell-surface receptor. However, more recently, additional cross-regulatory pathways have been identified that are potentially targetable. In this review, we address the current treatment landscape for CCA, the Hippo pathway broadly, animal models of CCA with attention to Hippo-related models, and the current strategies for targeting YAP.

References

Sep 27, 2001·Annals of Surgery·W R JarnaginL H Blumgart
Apr 18, 2007·Genes & Development·Duojia Pan
Nov 6, 2007·Current Biology : CB·Fernando D CamargoThijn R Brummelkamp
Jun 27, 2008·Genes & Development·Bin ZhaoKun-Liang Guan
Nov 19, 2008·Genes & Development·Xinwei CaoFred H Gage
Dec 17, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hashem B El-SeragThomas P Giordano
Feb 28, 2009·Gastroenterology·James E Everhart, Constance E Ruhl
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Hai SongYingzi Yang
Apr 9, 2010·The New England Journal of Medicine·Juan ValleUNKNOWN ABC-02 Trial Investigators
Jun 10, 2011·Nature·Sirio DupontStefano Piccolo
Nov 22, 2011·Liver International : Official Journal of the International Association for the Study of the Liver·Hua LiUdayan Apte
Apr 17, 2012·Human Pathology·Benjamin R KippKevin C Halling
Jun 5, 2012·Seminars in Cell & Developmental Biology·Wanjin Hong, Kun-Liang Guan
Sep 14, 2012·Genes & Development·Jung-Soon MoKun-Liang Guan
Sep 18, 2012·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Nataliya Razumilava, Gregory J Gores
Jan 30, 2013·Proceedings of the National Academy of Sciences of the United States of America·Run FanBarry M Gumbiner
Mar 8, 2013·Nature Reviews. Cancer·Kieran F HarveyDavid M Thomas
Oct 22, 2013·Gastroenterology·Sumera Rizvi, Gregory J Gores
May 20, 2014·Human Pathology·Rondell P GrahamBenjamin R Kipp
Oct 8, 2014·Physiological Reviews·Stefano PiccoloMichelangelo Cordenonsi
Jan 13, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Daisaku YamadaGregory J Gores
Mar 4, 2015·Nature·Koji TaniguchiMichael Karin
May 13, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edgar Ben-JosefCharles D Blanke
May 28, 2015·Oncotarget·Tiemin PeiLianxin Liu
Jul 16, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Patricia MartiJan S Tchorz
Dec 25, 2015·Proceedings of the National Academy of Sciences of the United States of America·Miki NishioAkira Suzuki
Jan 31, 2016·The Journal of Biological Chemistry·Sumera RizviGregory J Gores
Jul 29, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Hao WuXiong Ding
Jan 29, 2017·Proceedings of the National Academy of Sciences of the United States of America·Koji TaniguchiMichael Karin
Mar 9, 2017·Cell Reports·Sayan ChakrabortyWanjin Hong
Jul 27, 2017·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Xu-Feng ZhangTimothy M Pawlik
Dec 25, 2017·Journal of the American College of Surgeons·Kazunari SasakiTimothy M Pawlik
Apr 9, 2018·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Emilien LoeuillardSumera Rizvi
Nov 18, 2018·Nature Communications·Wei-Chien YuanFernando D Camargo

❮ Previous
Next ❯

Citations

May 30, 2020·International Journal of Oncology·Nicole A McgrathChangqing Xie
May 27, 2020·The Journal of Experimental Medicine·Qingxin ZhouZhiyong Zhang
Jul 2, 2020·Nature Reviews. Gastroenterology & Hepatology·Jesus M BanalesGregory J Gores
Nov 27, 2019·Cancers·Oihane EriceSilvestre Vicent
Dec 3, 2020·Annual Review of Pathology·Pedro M RodriguesJesus M Banales
Feb 25, 2021·Expert Opinion on Investigational Drugs·Massimiliano CadamuroLuca Fabris
Mar 27, 2021·Molecular Therapy. Nucleic Acids·Biqiang ZhuXiaohua Hou

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
xenografts

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.